Ticker

2L KRAS-Mutant MSS mCRC Demonstrates ~3–4x Improvement in Duration of Response vs. Historical 4–6 Month Benchmark Company Engaged with FDA to Support Potential Accelerated Approval Pathway in 2L RAS-Mutant MSS mCRC SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage company developing pelareorep, an investigational, systemically…

MONTEREY PARK, CA / ACCESS Newswire / April 29, 2026 / Maison Solutions Inc. (NASDAQ:MSS) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA IN RE MAISON SOLUTIONS INC.

MONTEREY PARK, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Maison Solutions Inc. (NASDAQ:MSS) today provided notice of proposed settlement of derivative actions and settlement hearing.

MONTEREY PARK, CA / ACCESS Newswire / April 22, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and merchandise to U.S. consumers, today announces that, as previously approved by the stockholders of the Company, it will implement a 1-for-10 reverse stock split of its outstanding shares of Class A common stock, effective on…

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.